Calendar of Canada Earnings Expected in the Week Ahead
Hamilton Thorne to Release Q2 2024 Financial Results on August 14, 2024
Hamilton Thorne Ltd. (TSE:HTL) Shares Could Be 49% Below Their Intrinsic Value Estimate
Hamilton Thorne Up Nearly 48%, on Pace for Largest Percent Increase Since December 2014 -- Data Talk
Hamilton Thorne Announces Agreement to Be Acquired by Astorg for CAD$2.25 Per Share in Cash
Hamilton Thorne Maintained at Buy at Stifel GMP on No Impact From U.S. IVF Actions; Price Target Kept at C$2.55
Hamilton Thorne Q1 Loss Widens Even as Sales Increase
Hamilton Thorne to Announce Q1 2024 Financial Results and Hold Conference Call on May 14, 2024
Hamilton Thorne Ltd.'s (TSE:HTL) Largest Shareholders Are Retail Investors With 51% Ownership, Institutions Own 33%
Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Earnings Call Summary | HAMILTON THORNE LTD(HTLZF.US) Q4 2023 Earnings Conference
Hamilton Thorne's Q4 Profit Falls, Sales Rise; Provides 2024 Outlook
Hamilton Thorne Brief: 2024 Guidance Is for a Sales Range Between US$78 and $82 Million Representing 10-15% Organic Growth; Q1 Guidance Is for a Sales Range of $19.0 to $19.4 Million
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023
Hamilton Thorne Maintained at Buy at Stifel GMP Ahead of Q4 Results; Price Target Kept at C$2.75
Hamilton Thorne to Announce Q4 and Full Year 2023 Financial Results and Hold Conference Call on March 27, 2024
Hamilton Thorne Appoints Dr. Ekaterina (Kate) Torchilin as President and CEO
Are Investors Undervaluing Hamilton Thorne Ltd. (TSE:HTL) By 40%?
Hamilton Thorne Ltd. Is Maintained at Buy by Stifel Nicolaus
Hamilton Thorne Ltd. Price Target Cut to C$2.20/Share From C$2.25 by Canaccord Genuity
No Data